首页> 美国卫生研究院文献>Springer Open Choice >In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem
【2h】

In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem

机译:卵黄/壳结构二氧化硅纳米系统体内靶向肿瘤的双峰PET /光学成像。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Silica nanoparticles have been one of the most promising nanosystems for biomedical applications due to their facile surface chemistry and non-toxic nature. However, it is still challenging to effectively deliver them into tumor sites and noninvasively visualize their in vivo biodistribution with excellent sensitivity and accuracy for effective cancer diagnosis. In this study, we design a yolk/shell-structured silica nanosystem 64Cu-NOTA-QD@HMSN-PEG-TRC105, which can be employed for tumor vasculature targeting and dual-modality PET/optical imaging, leading to superior targeting specificity, excellent imaging capability and more reliable diagnostic outcomes. By combining vasculature targeting, pH-sensitive drug delivery, and dual-modality imaging into a single platform, as-designed yolk/shell-structured silica nanosystems may be employed for the future image-guided tumor-targeted drug delivery, to further enable cancer theranostics.
机译:二氧化硅纳米粒子由于其易用的表面化学性质和无毒性质,已成为生物医学应用中最有前途的纳米系统之一。然而,将其有效地递送到肿瘤部位并以有效的癌症诊断的优异灵敏度和准确性无创地观察其体内生物分布仍然是挑战。在这项研究中,我们设计了一个卵黄/壳结构的二氧化硅纳米系统 64 Cu-NOTA-QD @ HMSN-PEG-TRC105,可用于肿瘤血管靶向和双峰PET /光学成像,从而具有出色的靶向特异性,出色的成像能力和更可靠的诊断结果。通过将血管靶向,pH敏感药物递送和双峰成像结合到一个平台中,可以将设计好的卵黄/壳结构二氧化硅纳米系统用于未来的图像引导的肿瘤靶向药物递送,以进一步实现癌症治疗学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号